Skip to main content
. 2022 Jul 2;12(7):930. doi: 10.3390/biom12070930

Figure 2.

Figure 2

HCC-deregulated microRNAs modulate both PD-L1 expression and tumorigenic pathways. Contemporaneous regulation of oncogenic genes and PD-L1 expression promotes HCC aggressiveness and immune escape of tumor cells. Green arrows: downregulated miRNAs/genes; red arrows upregulated miRNAs/genes.